Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heritable metabolic and dysplastic bone diseases.

M P Whyte1

  • 1Department of Medicine, Jewish Hospital of St. Louis, Washington University Medical Center, Missouri.

Endocrinology and Metabolism Clinics of North America
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Periodontal Defects in the A116T Knock-in Murine Model of Odontohypophosphatasia.

Journal of dental research·2015
Same author

Enzyme replacement therapy prevents dental defects in a model of hypophosphatasia.

Journal of dental research·2011
Same author

Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study.

The Journal of clinical endocrinology and metabolism·2010
Same author

Cementum and dentin in hypophosphatasia.

Journal of dental research·2005
Same author

Preonset studies of spondyloepiphyseal dysplasia tarda caused by a novel 2-base pair deletion in SEDL encoding sedlin.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2002
Same author

Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia.

Molecular genetics and metabolism·2001

Endocrinologists face challenges with rare metabolic bone diseases and genetic skeletal dysplasias. Some skeletal dysplasias involve metabolic components, potentially responding to hormonal or mineral therapy.

Area of Science:

  • Endocrinology
  • Genetics
  • Metabolic Bone Diseases

Background:

  • Rare heritable metabolic bone diseases and genetic skeletal dysplasias present diagnostic and therapeutic challenges.
  • Skeletal dysplasias significantly impact bone structure, prompting investigation into potential metabolic influences.

Purpose of the Study:

  • To explore the overlap between skeletal dysplasias and metabolic bone diseases.
  • To determine if skeletal dysplasias exhibit metabolic components treatable by endocrinologists.

Main Methods:

  • Review of clinical presentations and genetic profiles of skeletal dysplasias.
  • Analysis of mineral and hormonal homeostasis in affected patients.

Main Results:

  • Overt derangements in mineral homeostasis were identified in some skeletal dysplasias.

Related Experiment Videos

  • A subset of these conditions showed positive response to medical treatments targeting mineral or hormonal imbalances.

    • Conclusions:

    • Some genetic skeletal dysplasias possess treatable metabolic components, bridging the gap with traditional metabolic bone disorders.
    • Endocrinologists play a crucial role in managing both rare metabolic bone diseases and specific skeletal dysplasias.